Africa (WHO region) vs Bangladesh: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Africa (WHO region)
89.0%
in 2014
Bangladesh
100.0%
in 2014
Africa (WHO region) rank
2nd
Bangladesh rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Africa (WHO region)
- Bangladesh
How they compare
Bangladesh currently reports 100.0% against 89.0% in Africa (WHO region), a difference of 11.0%.
That makes Bangladesh's figure about 1.1 times Africa (WHO region)'s.
The two have swapped places 1 time across 7 shared years of data; in 2008 it was Africa (WHO region) ahead.
Africa (WHO region) ranks 2nd and Bangladesh ranks 1st of 11 groups.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Bangladesh | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.5% | 78.5% | 3.0% | Bangladesh |
| 2010s | 85.0% | 98.0% | 13.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Africa (WHO region) or Bangladesh?
- Bangladesh, at 100.0% against 89.0% in Africa (WHO region) as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Africa (WHO region) and Bangladesh?
- 11.0%, with Bangladesh ahead.
- How many years of comparable data are there for Africa (WHO region) and Bangladesh?
- 7 years are reported by both, from 2008 to 2014.
- How do Africa (WHO region) and Bangladesh rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Africa (WHO region) ranks 2nd and Bangladesh ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.